Factors That Influence the CR Rate
| Patient Characteristics . | No. of Patients . | No. of Patients in CR . | P Value* . |
|---|---|---|---|
| Total no. | 68 | 33 (48%) | |
| Age at MF diagnosis (yr) | |||
| <65 | 43 | 22 (51%) | .57 |
| >65 | 25 | 11 (44%) | |
| Sex | |||
| Male | 41 | 18 (44%) | .34 |
| Female | 27 | 15 (56%) | |
| Duration of symptoms before MF diagnosis (mo) | |||
| <120 | 54 | 25 (46%) | |
| >120 | 13 | 8 (62%) | .3 |
| Not determined | 1 | 0 | |
| T stage | |||
| T1 | 23 | 15 (65%) | |
| versus | .05 | ||
| T2 | 28 | 13 (46%) | |
| T3 | 8 | 1 (12.5%) | |
| T4 | 9 | 4 (44%) | |
| TNM staging | |||
| IA | 19 | 12 (63%) | |
| IB | 13 | 6 (46%) | |
| IIA | 16 | 7 (44%) | |
| versus | .34 | ||
| IIB | 5 | 1 (20%) | |
| III | 6 | 2 (33%) | |
| IV | 9 | 5 (55%) | |
| PCR | |||
| (−) | 26 | 18 (69%) | |
| (+) | 42 | 15 (36%) | .007 |
| Patient Characteristics . | No. of Patients . | No. of Patients in CR . | P Value* . |
|---|---|---|---|
| Total no. | 68 | 33 (48%) | |
| Age at MF diagnosis (yr) | |||
| <65 | 43 | 22 (51%) | .57 |
| >65 | 25 | 11 (44%) | |
| Sex | |||
| Male | 41 | 18 (44%) | .34 |
| Female | 27 | 15 (56%) | |
| Duration of symptoms before MF diagnosis (mo) | |||
| <120 | 54 | 25 (46%) | |
| >120 | 13 | 8 (62%) | .3 |
| Not determined | 1 | 0 | |
| T stage | |||
| T1 | 23 | 15 (65%) | |
| versus | .05 | ||
| T2 | 28 | 13 (46%) | |
| T3 | 8 | 1 (12.5%) | |
| T4 | 9 | 4 (44%) | |
| TNM staging | |||
| IA | 19 | 12 (63%) | |
| IB | 13 | 6 (46%) | |
| IIA | 16 | 7 (44%) | |
| versus | .34 | ||
| IIB | 5 | 1 (20%) | |
| III | 6 | 2 (33%) | |
| IV | 9 | 5 (55%) | |
| PCR | |||
| (−) | 26 | 18 (69%) | |
| (+) | 42 | 15 (36%) | .007 |
*χ2 or Yates corrected tests.